Analysis of rescue strategies for acute thrombosis during STA-MCA bypass surgery and the literature review
Authors:
Open Access
- 23 July 2024
- journal article
- research article
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 166 (1) , 1-8
Abstract
Background and objectives: STA-MCA bypass surgery is mainly used for Moyamoya disease, giant intracranial aneurysms, and resection of intracranial tumors requiring sacrifice of blood vessels. The intraoperative patency of the reconstructive vessels is critical to the efficacy of the procedure. This study aimed to evaluate the efficacy of intra-arterially infused tirofiban for the treatment of acute thrombosis during STA-MCA bypass surgery and countermeasures for acute thrombosis. Methods: This study involved 209 patients (272 hemispheres) who underwent STA-MCA surgery between November 2020 and December 2023. Intraoperative acute thrombosis occurred in eight patients (3.83%,8 hemispheres). We retrospectively reviewed the clinical and imaging data, surgical procedure, and follow-up outcomes of eight patients. We implemented the different thrombolytic methods to evaluate the optimal thrombosis management during the bypass surgery. After three months, we assessed neurological functions using the modified Rankin Scale (mRS) and conducted a literature review using PubMed. Results: Eight patients (four male patients and four female patients) developed acute thrombosis during the bypass surgery. Of the eight patients, two underwent re-anastomosis after thrombus removal, three received local injections of tirofiban into the anastomosis or the branches of the superficial temporal artery, and three underwent superselective intra-arterial tirofiban infusion using a microcatheter. Thrombosis were resolved, and arteries were recanalized in all patients. The mRS score was 0 in all patients. No major ischemic or hemorrhagic complications occurred. Conclusion: Our treatment methods were efficacious in the management of acute thrombosis. Intra-arterial tirofiban administration seems to be a simple and effective treatment option for acute thrombosis during STA-MCA bypass surgery.Keywords
All Related Versions
Funding Information
- Science and Technology Innovation 2025 Major Project of Ningbo Municipality (2022Z134)
- Ningbo Health Branding Subject Fund ((PPXK2018-04))
- Ningbo Top Medical and Health Research Program (2022020304)
- Zhejiang Traditional Chinese Medicine Scientific Research Fund Project (2021ZA129)
- Medical Scientific Research Foundation of Zhejiang Province (2021ZA129)
- Zhejiang Traditional Medicine and Technology Program (2020ZB216)
- Medical Scientific Research Foundation of Zhejiang Province (2020ky820)
This publication has 25 references indexed in Scilit:
- [Complications of Superficial Temporal Artery-Middle Cerebral Artery Anastomosis and Their Prevention: Technical Note].2022
- Rescue Strategy for Troublesome Situations Related to Recipient and Donor Arteries During Low-Flow Bypass SurgeryWorld Neurosurgery, 2021
- Low‐dose rescue tirofiban in mechanical thrombectomy for acute cerebral large‐artery occlusionEuropean Journal of Neurology, 2020
- Local in situ fibrinolysis for recanalization of an occluded extracranial-intracranial bypass: Technical noteJournal of Clinical Neuroscience, 2019
- Predictive factors for acute thrombogenesis occurring immediately after bypass procedure for moyamoya diseaseNeurosurgical Review, 2019
- Intraoperative Resuturing of Occluded Superficial Temporal Artery−Middle Cerebral Artery Anastomoses: Single-Center Retrospective StudyWorld Neurosurgery, 2018
- Mechanisms of Thrombus FormationNew England Journal of Medicine, 2008
- Thrombolytic agentsThrombosis and Haemostasis, 2005
- Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouseNature Medicine, 2002
- Bleeding Risk of Tirofiban, a Nonpeptide GPIIb/IIIa Platelet Receptor Antagonist in Progressive Stroke: An Open Pilot StudyCerebrovascular Diseases, 2001